Navigation Links
New bone-targeting drug delays onset of metastases in hormone-resistant prostate cancer patients
Date:9/24/2011

ed events (SREs), such as fractures and spinal cord compression. SREs can be profoundly disrupting to a patient's life and strategies to prevent or delay the spread of cancer to the bone can give them a respite from this.

If the osteoclast-mediated bone destruction can be hindered through inhibiting the RANKL protein, the cycle of bone destruction and tumour proliferation can be held back. Given that 90% of men with advanced prostate cancer will have their tumour spread to the bone, the potential advantages of RANKL inhibition are great, the researchers say.

"In this group of patients with castrate resistant prostate cancer, once they have developed bone metastases they are only likely to survive for around two years," says Prof Oudard. "Our trial has shown that denosumab prolongs the period before metastasis where the patients' quality of life has not yet suffered to a great extent. For the first time, we have shown that targeting the bone micro-environment can work in this way. We believe that in future we may be able to do even better by combining denosumab with other targeted treatments," he will conclude.

ECCO President Professor Michael Baumann said: "This is the first large clinical trial to demonstrate that targeting of the bone micro-environment significantly delays onset of bone metastases in hormone resistant prostate cancer patients with high risk for development of bone metastases. What is really striking here is that the effect holds true for all sub-groups of patients evaluated. This offers new options for a considerable group of patients and also will stimulate important further research in this field."

ESMO spokesman Dr. Joaquim Belmunt, from the Medical Oncology Service, Hospital del Mar, Barcelona, said: "Denosumab, being the first agent able to delay the onset of bone metastasis in castrate-resistant prostate cancer, represents a paradigm shift in our beliefs about the limited efficacy of the presently availa
'/>"/>

Contact: Mary Rice
mary.rice@riceconseil.eu
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Phase II study shows new cancer drug combination significantly delays breast cancer progression
2. Emergency treatment for heart attack improving but delays still occur
3. ADHD Drug Delays Puberty in Male Monkeys, Study Finds
4. One-Third of Severe Heart Attack Patients Have Treatment Delays
5. Many Pediatricians Arent Testing Tots for Developmental Delays
6. Hospital Delays Tied to Racial Divide in Heart Attack Care
7. Delays in Hospital Transfers for Heart Attack Patients May Raise Death Risk
8. Language Delays Seen in Kids in Institutions Beyond Age 2
9. Antifungal drug delays need for chemo in advanced prostate cancer
10. FDA Panel Delays Action on Dyes Used in Foods
11. Outcomes improved by longer delays between heart attacks and elective surgeries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Orlando, Florida (PRWEB) June 01, 2015 ... have generously donated $88,000 of the best superfood ... of the record-breaking floods in Texas. , "Monica ... Adams and Natural News in distributing Living Fuel Super ... victims of the millennial floods in Texas," KC Craichy ...
(Date:6/1/2015)... June 1, 2015 – Atlanta, GA – EB ... of hospital medicine, emergency medicine, and pediatric emergency medicine, ... its partnership with AgileMD to provide the content from ... mobile application format available on iPhones, iPads and ... excited about the June 1 launch of our hospital ...
(Date:6/1/2015)... The session, entitled “Building the Blueprint for Tomorrow’s ... Elektrobit Automotive Americas, senior representatives from Ford and ... moderated by Andy Gryc of CX3 Marketing. The discussion ... in-vehicle software in connected vehicles and autonomous cars, and ... wider ecosystem can fit into new vehicle software. ...
(Date:6/1/2015)... Strategic Radiology (SR) announced today that Rome Radiology ... the SR coalition of progressive, independent radiology groups geographically ... now have access to collective resources in all aspects ... deployment of subspecialized radiology services. With the addition of ... US based radiology group practices. , “We are ...
(Date:6/1/2015)... It can be difficult to keep ... protect both care providers and patients, so an inventor ... a way to put the "home" into the healthcare-supply ... home-healthcare products that promotes sanitary conditions in healthcare provision, ... from germs and disease. Overall, it allows for convenience ...
Breaking Medicine News(10 mins):Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 3Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 3Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 2Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 3Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 4
... 2008 Diplomat Specialty,Pharmacy today announced Mike ... of,National Accounts. Maynard reports directly to Dr. ... Maynard is responsible for the development and ... initially on chronic,kidney disease, dialysis, and renal ...
... NEW YORK, April 8, 2008 Lierac Paris, Europe,s,celebrated ... in select Healthy Skincare Centers at CVS/pharmacy throughout the,Northeast., ... Current store openings are as follows: ... by April 30, 2008 Northeast U.S. (NY ...
... microwave therapy for enlarged prostates experience significant surges in ... heart attack or stroke, according to new research findings ... Clinic-led study of 185 consecutive patients who received transurethral ... percent experienced systolic blood pressure surges of more than ...
... In short-term health care settings, sophisticated information technology ... care management, and enhance adherence to clinical guidelines. However, ... are unknown. In response to recent efforts from policy ... University of Missouri researcher found, through two different studies, ...
... by Attendees, BLACKWOOD, N.J., April 8, ... Healthcare Educational Forum in conjunction with,Wake Forest ... took,place in Winston-Salem, North Carolina on March ... integrated delivery networks and healthcare,information systems across ...
... April 8, 2008 ,GlaxoSmithKline (NYSE: GSK ) ... the US Food and Drug Administration (FDA) related ... a routine FDA,inspection of GSK,s reporting processes conducted ... primarily relate to omissions from,periodic reports to the ...
Cached Medicine News:Health News:Diplomat Specialty Pharmacy Hires National Accounts Director To Expand Kidney Disease Services 2Health News:Lierac Paris Expands in the United States at Healthy Skincare Centers at CVS/pharmacy 2Health News:Lierac Paris Expands in the United States at Healthy Skincare Centers at CVS/pharmacy 3Health News:Microwave treatments for enlarged prostate cause blood pressure surges 2Health News:Use of information technology is minimal in nursing homes 2Health News:Metrologic and Wake Forest University Baptist Medical Center Sponsored Healthcare Educational Forum 2Health News:Metrologic and Wake Forest University Baptist Medical Center Sponsored Healthcare Educational Forum 3Health News:GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting 2
(Date:6/1/2015)... , June 1, 2015 NEOVIA ... company engaged in the development and commercialization of ... that it has met with the U.S. Food ... the filing of an Investigational New Drug (IND) ... As a result of the meeting, Neovia has ...
(Date:6/1/2015)...   Royal Philips  (NYSE: PHG, AEX: PHIA) today ... to be showcased at the International Society for ... Annual Meeting & Exhibition in Toronto, Canada ... will see the latest in innovations designed in collaboration ... patient experience and provide economic value. The solutions highlight ...
(Date:6/1/2015)... -- Novel t reatments   entering ... says   GBI Research . ... be driven primarily by the introduction of numerous premium therapies, ... replace or combine with generic chemotherapies. Analysis from ... Cancer Market to 2020 - forecasts the value of ...
Breaking Medicine Technology:Neovia Oncology Announces First IND Meeting 2Philips showcases MR research solutions designed to enable collaboration with partners at the ISMRM Annual Meeting 2Philips showcases MR research solutions designed to enable collaboration with partners at the ISMRM Annual Meeting 3New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 3
... EASTON, Mass., March 19 Pressure,BioSciences, Inc. (Nasdaq: ... the Company and the Harvard School of Public ... simultaneous extraction, isolation, and,fractionation of nucleic acids (DNA ... samples routinely used in laboratory research. The method,is ...
... Meeting Indicates New Catheter-based, Treatment Could Soon ... DVT, WASHINGTON, March 19 Registry clinical ... Radiology,s 33rd Annual,Scientific Meeting shows DVT treatment with ... (Santa Clara, CA) successfully,breaks up the blood clot ...
Cached Medicine Technology:Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health 2Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health 3Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health 4Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: